INSIGHTS
Thought leadership, playbooks, and practical frameworks for investors and growth leaders.
Frequently Asked Questions
We work with private equity firms investing in product-driven businesses, particularly companies where the physical product, product portfolio or development process plays a meaningful role in growth, margin and enterprise value.
Our experience spans industrial equipment, machinery, robotics, medtech, scientific instruments, precision products, consumer products and other product-intensive sectors.
We do not stop at analysis or recommendations.
SARDI PRO CAPITAL operates as a Product Operating Partner, working alongside investment teams, management, R&D and product teams to turn product opportunities into decisions, roadmaps and real products in the market.
We combine an investor mindset with deep product development expertise—connecting product decisions directly to growth, margin improvement and enterprise value.
We can plug in across the entire investment lifecycle.
Before the deal, we help investors understand product potential, hidden risks and value creation opportunities.
During ownership, we work with portfolio companies to strengthen product portfolios, improve development velocity, simplify complexity and unlock new sources of value.
Ahead of exit, we help articulate product differentiation, scalability and future growth potential as part of a stronger equity story.
Our model is built around focused, intensive collaboration rather than long consulting cycles.
For core Product Operating Partner engagements, we typically immerse ourselves in the business for one month, concentrating the team around one clearly defined product value creation priority.
We work directly with the relevant functions, establish a rapid decision-making rhythm with leadership and move continuously from insight to decision to execution.
We work with them, not around them.
Internal teams already hold much of the knowledge required to unlock product value, but day-to-day operations often leave limited capacity for cross-functional transformation.
Our role is to add senior product expertise and execution capacity, connect perspectives across the organization, challenge assumptions and help teams make critical decisions faster.
The objective is not to replace internal capability, but to focus and accelerate it.
For us, skin in the game means being involved in execution.
We work inside the organization, help align stakeholders, accelerate decisions and convert product potential into an execution-ready roadmap.
Our success is tied to moving the product—and the investment thesis—forward.
Yes. We help investment teams assess the product side of a potential acquisition before the deal closes.
This can include reviewing the product portfolio, development pipeline, technical capabilities, cost structure, innovation potential and key product-related risks.
The objective is to identify where product can create value and translate those findings into clear implications for the investment thesis and post-close value creation plan.
Our approach is designed for private equity timelines, FORMULA SARDI, with monthly product developments.
We focus first on the few product decisions and opportunities that can have the greatest impact on growth, margin and enterprise value. By combining structured analysis with direct access to management and product teams, we can move quickly from diagnosis to prioritized action.
The goal is not to analyse everything. It is to identify what matters most and create momentum around it.
Absolutely.
FORMULA SARDI can be focused around a single high-value priority, such as product cost reduction, portfolio simplification, development acceleration, next-generation product strategy, product platforming or improving the new-product pipeline.
We define the scope around the investment thesis and the specific value creation opportunity.
